Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 265
Filter
1.
Acta Ortop Mex ; 35(4): 317-321, 2021.
Article in Spanish | MEDLINE | ID: mdl-35139589

ABSTRACT

INTRODUCTION: The cavus foot is a musculoskeletal pathology with an increase of the medial arch of the concavity of the foot. The etiology of the cavus foot is still enigmatic, it is related with neurologic conditions, Charcot-Marie-Tooth disease, Friedreich's ataxia, and cerebral palsy. The aim of this research was to analyze the plantar pressure distribution of the feet on young athletes with cavus foot. MATERIAL AND METHODS: Eighty-three young athletes between nine and 20 years old, that presented cavus feet pathology were recruited. The mass and height average were 56.9 ± 12.36 kg and 1.61 ± 0.10 m respectively. Plantar pressure distribution of the feet was recorded during static conditions. The hindfoot and forefoot pressure were compared in each foot. RESULTS: The plantar pressure distribution were categorized in three groups. In the first group the participants presented higher pressure in the hindfoot than forefoot, in the second group, the athletes showed similar pressure in the posterior and anterior region of the feet and in the last one, the subjects revealed higher pressure in the forefoot. To be considered in one of the three groups, the difference of pressure between the posterior and anterior part of the foot was established at 16%. CONCLUSION: Many musculoskeletal disorders in the human body are biomechanical in origin and related with foot anatomy. The cavus foot is a pathology with high prevalence in athletes and it is related with the mechanical forces over the feet during dynamic conditions.


INTRODUCCIÓN: El pie cavo es una patología musculoesquelética con un aumento del arco medial del pie. La etiología del pie cavo aún es incomprensible, está relacionada con afecciones neurológicas, enfermedad de Charcot-Marie-Tooth, ataxia de Friedreich y parálisis cerebral. El objetivo de esta investigación fue analizar la distribución de la presión plantar en atletas jóvenes con pie cavo. MATERIAL Y MÉTODOS: Se reclutaron 83 atletas jóvenes de entre nueve y 20 años de edad, que presentaban patología de pie cavo. La masa y el promedio de altura fueron 56.9 ± 12.36 kg y 1.61 ± 0.10 m, respectivamente. La distribución de la presión plantar de los pies se registró durante condiciones estáticas. Se compararon las presiones del antepié y el retropié. RESULTADOS: La distribución de la presión plantar se categorizó en tres grupos. En el primer grupo los participantes presentaron mayor presión en la parte anterior del pie; en el segundo grupo los atletas mostraron una presión similar en la región posterior y anterior de los pies y en el último los sujetos revelaron una mayor presión en el retropié. Para ser considerado en uno de los tres grupos, la diferencia de presión entre la parte posterior y anterior del pie se estableció en 16%. CONCLUSIÓN: Muchos trastornos musculoesqueléticos en el cuerpo humano son de origen biomecánico y están relacionados con la anatomía del pie. El pie cavo es una patología con alta prevalencia en atletas y está relacionada con las fuerzas mecánicas sobre los pies en condiciones dinámicas.


Subject(s)
Talipes Cavus , Adolescent , Adult , Athletes , Biomechanical Phenomena , Child , Humans , Pressure , Risk Factors , Young Adult
2.
Acta Ortop Mex ; 32(2): 82-87, 2018.
Article in Spanish | MEDLINE | ID: mdl-30182553

ABSTRACT

The insufficiency of the posterior tibial tendon is the most common acquired cause of pain related to valgus flatfoot deformity in adults. The acquired flatfoot adult is a very painful symptomatic deformity resulting from a gradual stretching (attenuation) of the posterior tibial tendon and ligaments that support the arch of the foot. The progressive pain acquired flatfoot adult affects four times more women than men. Some factors that contribute to increased risk of acquired flatfoot in adults, are diabetes, hypertension and obesity. It is thought that the combination of the following events is the cause of acquired flatfoot adult. Johnson Strom classification modified by Mayerson evaluates in 4 stages. This study was divided into 3 stages: Stage 1: Dissection and three-dimensional analysis of the tendon, Step 2: Application of tools bioengineering to determine the causes of rupture of the tibial tendon: Stage 3: Evaluation of 24 patients with flatfoot disease valgus for describe the deformity.


La insuficiencia del tendón del tibial posterior es la causa adquirida de dolor más común relacionada con la deformidad de pie plano valgo en adultos. El pie plano adquirido por el adulto es una deformidad sintomática muy dolorosa que resulta de un estiramiento gradual (atenuación) del tendón del tibial posterior, así como de los ligamentos que sostienen el arco de la planta del pie. El dolor progresivo en el pie plano adquirido por el adulto afecta cuatro veces más a las mujeres que a los hombres. Algunos factores que contribuyen a incrementar el riesgo del pie plano adquirido en el adulto son la diabetes, la hipertensión y la obesidad. Se piensa que la combinación de los eventos siguientes es la causa del pie plano adquirido por el adulto. La clasificación de Johnson Strom modificada por Mayerson lo evalúa en cuatro estadios. Este estudio se dividió en tres etapas: etapa 1: disección y análisis tridimensional del tendón, etapa 2: aplicación de herramientas de bioingeniería para determinar las causas de ruptura del tendón del tibial posterior y etapa 3: evaluación de 24 pacientes con enfermedad de pie plano valgo para describir la deformidad.


Subject(s)
Flatfoot , Posterior Tibial Tendon Dysfunction , Adult , Female , Flatfoot/complications , Foot , Humans , Male , Posterior Tibial Tendon Dysfunction/etiology , Rupture , Tibia
3.
Acta Ortop Mex ; 31(3): 118-122, 2017.
Article in Spanish | MEDLINE | ID: mdl-29216701

ABSTRACT

BACKGROUND: There are many surgical options for the treatment of hallux valgus in combination with capsular repairs for the correction of hallux valgus. MATERIAL AND METHODS: This report corresponds to a descriptive study where a new capsulorrhaphy technique in hallux valgus is proposed. Six dissections were performed on cadavers with hallux valgus deformity using the following surgical technique: medial approach on the first toe longitudinally, dissecting by planes and locating the metatarsophalangeal joint capsule; it was incised longitudinally. The capsule was separated and an exostectomy of the first metatarsal head was done, the edges were regularized and a release of the abductor hallucis was performed. Later, the capsular remnant was resected and repaired. RESULTS: Six cadaveric feet with hallux valgus were studied, five with mild deformity, one with moderate deformity, one foot with the 2nd finger on supraductus. DISCUSSION: Many capsular repairs have been reported in the literature, including «L¼, triangular, «V-Y¼, rectangular, with satisfactory results, along with osteotomy of the first metatarsal. In this report, a new capsular repair was described. CONCLUSION: Applying this new capsular repair, we reduced the metatarsophalangeal and intermetatarsal angles and achieved a capsular closure with suitable tension; the metatarsophalangeal joint mobility was preserved.


ANTECEDENTES: Existen numerosas técnicas quirúrgicas para el tratamiento del hallux valgus en combinación con diversas capsulorrafias para su corrección. MATERIAL Y MÉTODOS: El trabajo presentado corresponde a un estudio descriptivo donde se propone una capsulorrafia no desarrollada con anterioridad del hallux valgus. Se realizaron seis disecciones en cadáver con la deformidad de hallux valgus a través de la siguiente técnica quirúrgica: abordaje medial sobre el primer dedo del pie de manera longitudinal, disecando por planos y localizando la cápsula articular metatarsofalángica; se incidió longitudinalmente. Se separó la cápsula y se llevó a cabo la exostectomía de la cabeza del primer metatarsiano; se regularizaron los bordes y se realizó la liberación del abductor del primer dedo. Posteriormente, se resecó el remanente capsular y se reparó. RESULTADOS: Seis pies de cadáver portadores de hallux valgus; cinco con deformidad leve, uno pie moderado, un pie con segundo dedo en supraducto. DISCUSIÓN: Muchas capsulorrafias han sido reportadas en la literatura, incluyendo en «L¼, triangular, «V-Y¼, rectangular, con resultados satisfactorios, junto con las osteotomías del primer metatarsiano. Aquí se describe una propuesta de capsulorrafia. CONCLUSIÓN: La corrección de la deformidad del hallux valgus en pies de cadáver aplicando esta propuesta de reparación capsular fue satisfactoria, con adecuada tensión y una movilidad conservada de la articulación metatarsofalángica.


Subject(s)
Hallux Valgus , Metatarsophalangeal Joint , Osteotomy , Cadaver , Hallux Valgus/surgery , Humans , Metatarsal Bones , Metatarsophalangeal Joint/surgery
4.
Nucleosides Nucleotides Nucleic Acids ; 29(4-6): 325-9, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20544515

ABSTRACT

Gout is commonly associated with obesity, arterial hypertension, diabetes, and dyslipidemia. However, the prevalence of metabolic syndrome has not been widely recognized in patients with gout. We studied 41 patients (37 males) with primary gout to assess the prevalence and characteristics of the associated metabolic syndrome. Twenty-one patients with gout (51%) showed >or=3 criteria for the metabolic syndrome. Pathological conditions associated were obesity (21/41), high blood pressure (30/41), dyslipidemia (30/41), and fasting plasma glucose >or= 100 mg/dL (22/41). The most frequent triad was the presence of increased waist circumference, elevated fasting plasma glucose, and hypertension. Mean serum urate concentration did not differ significantly in gout patients with the metabolic syndrome (8.5 mg/dl) and without (8.1 mg/dl). Given the complications associated with metabolic syndrome, its diagnosis may determine the long-term treatment of patients with gout.


Subject(s)
Gout/blood , Gout/pathology , Metabolic Syndrome/blood , Metabolic Syndrome/pathology , Aged , Blood Glucose/metabolism , Blood Pressure/physiology , Female , Gout/complications , Humans , Hyperuricemia/blood , Hyperuricemia/pathology , Male , Middle Aged , Uric Acid/blood , Waist Circumference
5.
Nucleosides Nucleotides Nucleic Acids ; 29(4-6): 330-4, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20544516

ABSTRACT

Forty-four patients (40 males) with a mean age of 58 years were included in this pilot study. Mean serum urate concentration in patients with and without the metabolic syndrome (MS) was 8.8 mg/dL and 8.1 mg/dL, respectively. Urinary uric acid excretion was 543 mg/day/1.73 m(2) in the former and 609 mg/day/1.73 m(2) in the latter. Uric acid to creatinine ratio was 0.37 mg/mg in patients with the MS and 0.42 mg/mg in those without the MS. Mean serum urate increased from 8.6 mg/dL in subjects with three or more MS components to 10.3 mg/dL in those with five MS components. Serum urate was markedly lower in patients with mild MS (9 patients, 8.6 mg/dL) as compared to severe MS (10 patients, 9.2 mg/dL). In contrast, urinary uric acid to creatinine ratio was 0.42 mg/mg in patients with gout and mild MS and 0.33 mg/mg in gout patients with severe MS. Uric acid underexcretion appears to be more severe in gout patients with the MS. This disturbance appears to be related to the severity of the MS.


Subject(s)
Gout/complications , Metabolic Syndrome/complications , Uric Acid/metabolism , Female , Gout/blood , Gout/urine , Humans , Male , Metabolic Syndrome/blood , Metabolic Syndrome/urine , Middle Aged , Uric Acid/blood , Uric Acid/urine
6.
Transplant Proc ; 41(6): 2427-9, 2009.
Article in English | MEDLINE | ID: mdl-19715941

ABSTRACT

OBJECTIVE: To evaluate the safety and efficacy of nitinol stents and the Detour extra-anatomical ureteral bypass graft in treatment of ureteral stenosis after kidney transplantation. PATIENTS AND METHODS: Eighteen kidney transplant recipients with complex stenosis caused by failure of primary treatment or with high surgical risk or a poorly functioning graft (serum creatinine concentration >2.5 mg/dL) were treated using antegrade percutaneous implantation of nitinol stents (n = 16) or extra-anatomical ureteral bypass grafts (n = 3); 1 patient was treated with both techniques. RESULTS: Mean (range) follow-up of ureteral stents was 51.2 (3-118) months. Patency rate at last follow-up, resumption of dialysis therapy, or death was 75% (12 of 16 patients). In 4 patients (25%), stent occlusion developed, which was treated using a double-J catheter in 2 patients, stent removal and pyeloureterostomy using the native ureter in 1 patient, and implantation of an extra-anatomical bypass graft in 1 patient. Mean follow-up in patients with extra-anatomical ureteral bypass grafts was 32 (8-64) months. One patient developed a urinary tract infection, and another had encrustation with obstruction. CONCLUSIONS: Use of nitinol ureteral stents and extra-anatomical ureteral bypass grafts is a safe and effective alternative to surgery for treatment of post-kidney transplantation ureteral stenosis in patients with chronic graft dysfunction, those at high surgical risk, and those in whom previous surgical treatment has failed.


Subject(s)
Kidney Transplantation/adverse effects , Prosthesis Implantation/methods , Stents , Ureteral Diseases/etiology , Ureteral Diseases/surgery , Ureterostomy , Adult , Aged , Constriction, Pathologic/etiology , Constriction, Pathologic/surgery , Female , Follow-Up Studies , Humans , Kidney Function Tests , Kidney Transplantation/mortality , Male , Middle Aged , Prosthesis Implantation/standards , Renal Replacement Therapy , Retrospective Studies , Safety , Survival Rate , Ureteral Diseases/mortality , Ureteral Diseases/pathology
7.
Int J Tuberc Lung Dis ; 10(4): 409-14, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16602405

ABSTRACT

OBJECTIVE: To evaluate the results of the treatment of non-HIV-infected multidrug-resistant tuberculosis (MDR-TB) patients admitted to a tuberculosis unit in a reference centre between June 1998 and December 2000. RESULTS: Twenty-five patients were studied (23 men). Empirical treatment was selected according to drugs previously used and adjusted according to in vitro test results. Patients had previously received an average of 5.5 drugs and were resistant to an average of 4.7 drugs. They were treated with a median number of four drugs (an injectable drug plus three oral drugs) for a median of 18 months. Ofloxacin and cycloserine was used in 17 cases (68%), ethionamide/prothionamide in 18 (72%) and para-aminosalicylic acid in 12 patients (48%). Psychological support and counselling was provided. Two patients required surgery. Globally, 21 patients (84%) met cure criteria. After a 24-month follow-up, none of the 21 patients who successfully completed treatment presented relapse or death. CONCLUSION: MDR-TB is a curable disease in non-HIV-infected patients. Individualised treatment regimens should be based on treatment history and the study of in vitro susceptibility and by promoting a relationship with the patient that makes adherence to treatment easier and minimises side effects.


Subject(s)
Antitubercular Agents/therapeutic use , Tuberculosis, Multidrug-Resistant/drug therapy , Adult , Aged , Female , Follow-Up Studies , HIV/immunology , HIV Antibodies/analysis , HIV Infections/virology , Humans , Male , Middle Aged , Mycobacterium tuberculosis/isolation & purification , Retrospective Studies , Sputum/microbiology , Treatment Outcome , Tuberculosis, Multidrug-Resistant/microbiology
8.
Clin Rheumatol ; 25(4): 537-9, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16208429

ABSTRACT

OBJECTIVE: To evaluate bone mineral metabolism in HIV infected and asymptomatic patients receiving highly active antiretroviral therapy (HAART) containing protease inhibitors (PI) and naïve patients. METHODS: We studied 30 asymptomatic HIV infected male patients, 13 in the naive group and 17 in the IP group, both without differences in demographics characteristics. We excluded women and patients with any known factor associated to osteopenia. We did a nutritional questionnaire, a DEXA scan in lumbar spine and femur, a study of CD4 lymphocytes, viral load and an analysis of bone formation and resorption markers in all patients. We compared vitamin D and PTH levels with a control group of healthy male volunteers age-pareated. For the statistical analysis we used the SPSS program. RESULTS: Osteopenia was present in 17/30 (57%), 8/13 (61.5%) in the naïve group and 9/17 (53%) in the PI group (not significant differences). We found a vitamin D deficiency in 86% of patients, with mean serum levels that was found to be significantly lower than those from a healthy control group (p=0.04). Testosterone level was significantly related to bone mineral density in lumbar spine (p

Subject(s)
Bone Density , Bone Diseases, Metabolic/complications , HIV Infections/complications , HIV Infections/drug therapy , HIV Protease Inhibitors/therapeutic use , Adult , Antiretroviral Therapy, Highly Active/adverse effects , Biomarkers/blood , Bone Diseases, Metabolic/diagnosis , Bone Diseases, Metabolic/etiology , HIV Infections/blood , HIV Protease Inhibitors/adverse effects , Humans , Male , Nutritional Status , Parathyroid Hormone/blood , Reference Values , Testosterone/blood , Vitamin D/blood , Vitamin D Deficiency/complications , Vitamin D Deficiency/diagnosis
9.
AIDS ; 19(13): 1361-5, 2005 Sep 02.
Article in English | MEDLINE | ID: mdl-16103766

ABSTRACT

INTRODUCTION: There are very limited data about the prevalence of multiple hepatitis virus infections in HIV infected individuals. In HIV uninfected individuals with triple BCD hepatitis, hepatitis D virus (HDV) appears to be the dominant virus. However, in HIV infected patients with triple hepatitis it is not known if HDV replication inhibits hepatitis B virus (HBV) and/or hepatitis C virus (HCV) replication. METHODS: We calculated the prevalence of single (B or C), dual (BC) and triple (BCD) hepatitis in 423 HIV-infected patients with positive HCV serum antibodies and/or positive serum HBsAg. In patients with multiple infections we performed an evaluation of serum markers of HBV, HCV and HDV replication. RESULTS: The prevalence of multiple hepatitis was 4.7% (95% confidence interval, 2.7-6.7%). Multiple hepatitis occurred only among patients who acquired HIV through injection drug use. The most common multiple hepatitis was triple BCD. Patients with hepatitis BC and past or chronic hepatitis D were significantly more likely to have cirrhosis and a negative serum HBeAg and HCV PCR than patients with single hepatitis B or hepatitis C. Patients with chronic hepatitis D showed uniform suppression of HBV and HCV replication markers. CONCLUSIONS: In our geographic area approximately 5% of HIV infected patients with hepatitis suffer multiple hepatitis virus infection. In patients with triple hepatitis BCD virus infection, HDV appears to be the dominant virus causing inhibition of both HBV and HCV replication.


Subject(s)
HIV Infections/complications , Hepatitis, Viral, Human/complications , Adult , Antiretroviral Therapy, Highly Active , Cross-Sectional Studies , Female , HIV Infections/drug therapy , Hepatitis B, Chronic/complications , Hepatitis C, Chronic/complications , Hepatitis D/complications , Humans , Male , Middle Aged , Superinfection/complications , Viral Interference
10.
J Antimicrob Chemother ; 55(5): 800-4, 2005 May.
Article in English | MEDLINE | ID: mdl-15761071

ABSTRACT

OBJECTIVES: The aim of this study was to evaluate the frequency, characteristics and risk factors of lipid changes associated with lopinavir/ritonavir treatment in antiretroviral-naive patients. METHODS: A prospective cohort of 107 antiretroviral-naive HIV-infected patients was followed for 12 months after starting lopinavir/ritonavir-based highly active antiretroviral therapy. RESULTS: At 12 months, percentages of patients with hypercholesterolaemia and hypertriglyceridaemia were 17.4% and 40%, respectively. Mean increases in total cholesterol and triglycerides were 40.7 and 73.3 mg/dL. There was a significant increase in both low-density and high-density (HDL) cholesterol, and no increase in the total cholesterol/HDL ratio (from 4.16 at baseline to 4.49 after 12 months). Baseline cholesterol > 200 mg/dL and triglycerides > 150 mg/dL were independent risk factors for dyslipidaemia, while hepatitis C coinfection appeared to be protective. CONCLUSIONS: Patients with elevated lipid values at baseline have the greatest risk of developing hypercholesterolaemia and hypertriglyceridaemia after starting lopinavir/ritonavir. Antiretroviral-naive patients coinfected with hepatitis C have a low risk of developing hyperlipidaemia after starting lopinavir/ritonavir.


Subject(s)
Antiretroviral Therapy, Highly Active , HIV Infections/drug therapy , HIV Protease Inhibitors/adverse effects , Hyperlipidemias/chemically induced , Pyrimidinones/adverse effects , Ritonavir/adverse effects , Adult , Aged , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Female , HIV Infections/complications , HIV Protease Inhibitors/therapeutic use , Hepatitis C/complications , Humans , Hypercholesterolemia/chemically induced , Hypertriglyceridemia/chemically induced , Lipids/blood , Lopinavir , Male , Middle Aged , Pyrimidinones/therapeutic use , Risk Factors , Ritonavir/therapeutic use , Triglycerides/blood
11.
Eur J Clin Microbiol Infect Dis ; 23(2): 111-5, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14735402

ABSTRACT

The purpose of this study was to analyze the quantitation of the human immunodeficiency virus type 1 RNA (HIV-1 RNA) in the genital tract of HIV-1-infected pregnant women and to evaluate a possible correlation with the viral load in blood plasma (Spearman's rank correlation coefficient). A total of 38 each of cervical, vaginal, and blood samples from 38 women were obtained during the third trimester of pregnancy for quantitation of the HIV-1 RNA load. Viral loads were determined by reverse transcription-polymerase chain reaction. The HIV-1 RNA viral load was detectable in 29 of the 38 (76.3%) blood samples, in 6 of the 38 (15.7%) cervical secretion samples, and in 8 of the 38 (21%) vaginal secretion samples. Overall, the correlation between the HIV-1 RNA viral load in the blood plasma and in cervical secretion samples was 0.51 ( P<0.001). However, the correlation disappeared ( r=0.27) when three patients with high blood plasma viral loads were eliminated from the statistical study. The viral load in the vaginal secretions did not correlate with that in the blood samples ( r=0.26). There were two cases in which HIV-1 RNA was undetectable in the blood and cervix but was detectable in vaginal secretions: one woman had 220 copies/ml and the other 68 copies/ml. These results suggest that pregnant women with undetectable viral loads in blood plasma are still at risk of transmitting the virus vertically during vaginal delivery. Because of this, antiretroviral prophylaxis during vaginal delivery must be administered to HIV-1-infected women and their newborns, regardless of the mother's viral load in plasma. In conclusion, quantification of cervicovaginal levels of HIV-1 may represent a useful tool for assessing the individual risk associated with a vaginal delivery and for guiding decisions about whether a scheduled caesarean should be recommended.


Subject(s)
HIV Infections/diagnosis , HIV-1/immunology , Pregnancy Complications, Infectious/diagnosis , Viral Load , Virus Shedding/physiology , Adult , Cervix Uteri/virology , Female , HIV Infections/transmission , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical/prevention & control , Pregnancy , Pregnancy Trimester, Third , Probability , Prospective Studies , RNA, Viral/analysis , Reverse Transcriptase Polymerase Chain Reaction/methods , Risk Assessment , Sampling Studies , Sensitivity and Specificity , Vagina/metabolism , Vagina/virology , Vaginal Smears
12.
Eur J Clin Microbiol Infect Dis ; 22(6): 360-3, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12750959

ABSTRACT

Fifty-four cases of Achromobacter xylosoxidans bacteremia diagnosed over a 10-year period in patients from 2 months to 87 years of age were reviewed. Fifty-two episodes were nosocomial. The most frequent underlying condition was neoplasm (solid or hematological). The source of infection was a contaminated intravenous catheter in 35 patients (60%) and pneumonia in 6 patients. Eight (15%) patients died. The only risk factors significantly associated with mortality were age over 65 years and neutropenia. The results of in vitro susceptibility studies of the isolates showed that antibiotic therapy with antipseudomonal penicillins or carbapenems would be a reasonable choice. An epidemiological study conducted in the hemodialysis unit showed Achromobacter xylosoxidans in tap water and on the hands of two healthcare workers but not in the hemodialysis systems. Patients were probably contaminated when healthcare workers manipulated the intravenous catheters without wearing gloves.


Subject(s)
Alcaligenes/isolation & purification , Bacteremia/epidemiology , Gram-Negative Bacterial Infections/epidemiology , Gram-Negative Bacterial Infections/microbiology , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Analysis of Variance , Anti-Bacterial Agents/therapeutic use , Bacteremia/diagnosis , Bacteremia/drug therapy , Child , Child, Preschool , Cohort Studies , Cross Infection/drug therapy , Cross Infection/epidemiology , Cross Infection/microbiology , Female , Gram-Negative Bacterial Infections/drug therapy , Humans , Incidence , Infant , Male , Microbial Sensitivity Tests , Middle Aged , Probability , Retrospective Studies , Risk Factors , Sex Distribution , Spain/epidemiology , Survival Analysis
13.
Am J Gastroenterol ; 98(3): 568-77, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12650789

ABSTRACT

OBJECTIVE: Because of the low incidence of pancreatic ascites, only case reports and case series have been published, and no randomized controlled trials have been performed to find out which is the best therapeutic approach. The aim of this study was to evaluate the utility of the different treatments for pancreatic ascites by a thorough review of all case reports described in the literature in which an independent analysis of the efficacy of the treatment administered to each patient is possible. METHODS: We conducted an analysis of all case reports and case series of pancreatic ascites published between 1975 and 2000 in which clinical data of every patient could be identified individually. A total of 139 cases were studied. Clinical characteristics, treatments administered, and response to therapy of every patient were registered. Conservative therapy included drainage of ascitic fluid, total parenteral nutrition and diet, and somatostatin analogues. Interventional therapy was either endoscopic or surgical. RESULTS: After multivariate analysis, the only treatments related to success were surgery (adjusted OR = 8.2, 95% CI = 3.0-22.9) and transpapillary stent (adjusted OR = 7.3, 95% CI = 0.8-62.9). No significant relationship was found between failure or death and the use of other treatments, age, sex, year of publication, underlying disease, site of leakage, or serum amylase levels. The apparent lack of effect of somatostatin analogues could be attributed to the small number of cases and the heterogeneity of the dosages. CONCLUSIONS: Conservative therapy is not advisable for pancreatic ascites because of the high proportion of failures. Interventional therapy with surgery or transpapillary stent has a positive effect in the clinical outcome.


Subject(s)
Ascites/etiology , Ascites/therapy , Digestive System Surgical Procedures/methods , Gastrointestinal Agents/therapeutic use , Pancreatic Diseases/complications , Adolescent , Adult , Aged , Analysis of Variance , Ascites/drug therapy , Ascites/surgery , Child, Preschool , Female , Hormones/therapeutic use , Humans , Infant , Male , Middle Aged , Octreotide/therapeutic use , Parenteral Nutrition, Total , Retrospective Studies , Somatostatin/therapeutic use , Stents , Treatment Outcome
15.
J Med ; 32(3-4): 152-62, 2001.
Article in English | MEDLINE | ID: mdl-11563813

ABSTRACT

Fever of unknown origin (FUO) associated with HIV infection is different from classic FUO. Relevant etiologies, procedures and time to diagnosis were analyzed. Patients admitted with FUO from 1991 to 1996 were prospectively followed. Thirty with classic FUO (group I) and 46 with FUO and HIV (group II) were included. Data on diagnosis, time to achieve it, and procedures were registered. Diagnosis was obtained in 87% and 93% of cases in groups I and II. Infections were the most frequent cause in group II. Collagen diseases were found in group I and absent in group II. Prevalence of neoplasia was similar. Mean time to diagnosis was near 5 weeks. In HIV the predominant diagnostic method was the Lowenstein culture. Invasive methods were similarly employed. It is concluded that predominance of Mycobacteria and absence of collagen diseases make FUO associated with HIV a different form of FUO. No differences were found in approach and time to diagnosis.


Subject(s)
Fever of Unknown Origin/etiology , HIV Infections/complications , Adult , Collagen Diseases/complications , Female , Humans , Infections/complications , Male , Middle Aged , Neoplasms/complications , Prospective Studies
18.
Horm Metab Res ; 32(10): 407-12, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11069205

ABSTRACT

OBJECTIVE: To test whether oxidative stress could promote a systemic acute-phase response in elderly patients with type II diabetes. DESIGN AND METHODS: In a group of 30 older diabetic patients with poor glycemic control, serum levels of lipid peroxides, measured as thiobarbituric acid-reacting substances (TBARS); C-reactive protein (CRP); interleukin (IL)-6 and the soluble form of its receptor (slL-6R), were evaluated at baseline and after 2 and 3 months of therapeutic intervention. Thirty asymptomatic, untreated individuals with abnormal fasting glycemia, but otherwise healthy status, of similar age, sex, and weight served as control group. RESULTS: At baseline, glycemia (8.83 +/- 0.67mmol/l), HbA1C (8.66 +/- 0.59%), TBARS (8.68 +/- 1.21 micromol/l), CRP (16.05 +/- 3.81 mg/l) IL-6 (5.39 +/- 1.25 pg/ml) and sIL-6R (1425 +/- 492 pg/ml) were significantly higher in diabetic patients than in asymptomatic hyperglycemic individuals (p<0.001). After treatment, glycemia significantly decreased with respect to baseline values (- 9.82% after 60 days and -13.74% after 90 days), as did serum levels of TBARS (-14.05% and -21.89%, respectively), CRP (-32.71% and -43.86%), IL-6 (-23.75% and -40.63%) and sIL-6R (-34.53% and -48.49%, respectively). In diabetic patients, multiple regression showed, at each time, that TBARS and IL-6 were independently correlated with CRP, considering CRP as the dependent variable. Similar correlations were found in asymptomatic hyperglycemic subjects. CONCLUSION: These results suggest that oxidative stress might be implicated in promoting a state of low-grade systemic inflammation in elderly patients with type II diabetes.


Subject(s)
Acute-Phase Reaction/metabolism , Diabetes Mellitus, Type 2/metabolism , Oxidative Stress/physiology , Aged , C-Reactive Protein/metabolism , Diabetes Mellitus, Type 2/diet therapy , Diabetes Mellitus, Type 2/drug therapy , Female , Humans , Hyperglycemia/blood , Interleukin-6/metabolism , Male , Receptors, Interleukin-6/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
19.
Life Sci ; 67(11): 1317-24, 2000 Aug 04.
Article in English | MEDLINE | ID: mdl-10972200

ABSTRACT

Since moderate hyperhomocysteinemia is an independent risk factor for vascular disease by mean of its oxidant effect and glutathione plays a main role as intracellular redox-regulating agent, we have studied for the first time the total intracellular content of homocysteine in aging. Plasma homocysteine concentration, total intracellular and plasma glutathione, and other related thiol compounds such as cysteine and the glutathione catabolite cysteinglycine were also studied. Forty three healthy elderly subjects and twenty seven healthy young ones were studied. The total intracellular peripheral blood mononuclear cell content was higher for homocysteine, cysteine and cysteinglycine, whereas that of the total glutathione was greatly decreased in elderly people with respect to young ones. Elderly subjects showed significantly higher levels than young ones of total plasma homocysteine and cysteinglycine, but not cysteine, whereas total plasma glutathione levels were increased. In addition, elderly subjects showed significantly decreased plasma vitamin E levels and increased concentrations of serum lipid peroxides measured as TBARS (reaction product of malondialdehyde with thiobarbituric acid). The intracellular glutathione content presented significantly negative correlation with serum TBARS, and intracellular and plasma homocysteine levels. These findings show an increase of homocysteine synthesis associated with aging, which in turn can produce an augmented oxidant effect on endothelium, and an impaired intracellular antioxidant capacity leading to an enhanced lipid peroxidation and decreased total intracellular glutathione content.


Subject(s)
Aging/blood , Glutathione/blood , Homocysteine/blood , Aged , Aged, 80 and over , Female , Humans , Male , Thiobarbituric Acid Reactive Substances/metabolism , Vitamin E/blood
20.
Med Clin (Barc) ; 114(18): 690-3, 2000 May 13.
Article in Spanish | MEDLINE | ID: mdl-10916789

ABSTRACT

BACKGROUND: Day care units have become an usual way of medical care for AIDS patients. However, their influence on the incidence of hospital admissions has not been evaluated. METHODS: Observational and longitudinal study of a cohort of 308 patients with aids diagnosed between 1990 and 1994 and followed-up to June 1996. The incidence of hospital admissions according to the hospital of follow-up (with or without day care unit) was analyzed. A multivariate analysis of the number of hospital admissions was performed using regression model adjusted to a distribution of Poisson. RESULTS: After AIDS diagnosis, the incidence of hospital admissions was 108 per 100 patient-years of follow up (21 days as inpatient per patient-year). Those patients controlled in the hospital with day care unit have less hospital admissions (relative risk after adjusting by CD4+ cells count and type of diagnostic disease: 0.64; CI95% 0.55-0.76), and less days as inpatient through their follow-up (11 to 31 days less). There was no difference in survival among patients followed in both hospitals. CONCLUSIONS: A day care unit decrease the incidence of hospital admissions in aids patients. This positive impact is more evident in patients with lesser CD4+ cell counts.


Subject(s)
Acquired Immunodeficiency Syndrome/rehabilitation , Ambulatory Care/statistics & numerical data , Patient Admission/statistics & numerical data , Acquired Immunodeficiency Syndrome/blood , Adult , CD4 Antigens/blood , Female , Follow-Up Studies , Hospitalization/statistics & numerical data , Humans , Incidence , Length of Stay/statistics & numerical data , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...